Section 33-24-148 - Conditions for drug substitution(a) Repealed By Laws 2001, Ch. 54, § 2.(b) Except as limited by W.S. 33-24-149(b) or when the practitioner has clearly indicated substitution is not permitted, a pharmacist may substitute: (i) A drug product with the same generic name in the identical strength, quantity, dose and dosage form as the prescribed drug, provided the substituted product or drug meets all requirements specified in W.S. 33-24-147(a)(ii);(ii) An interchangeable biological product.(c) Repealed By Laws 2001, Ch. 54, § 2.(d) Repealed By Laws 2001, Ch. 54, § 2.(e) A pharmacist may not substitute a generically equivalent drug unless it has been manufactured with the following minimum manufacturing standards and practices by a manufacturer who: (i) Marks capsules and tablets with an identification code or monogram;(ii) Labels products with their expiration date;(iii) Maintains reasonable resources for product information;(iv) Maintains recall capabilities for unsafe or defective drugs.(f) Repealed By Laws 2001, Ch. 54, § 2.(g) When a practitioner orally communicates a prescription and prohibits substitution of an interchangeable biological product or generically equivalent drug, the pharmacist shall make reasonable efforts to obtain a written prescription from the practitioner with the phrase "brand medically necessary" written on the face of the prescription in his own handwriting.Amended by Laws 2018 , ch. 93, § 1, eff. 7/1/2018.